Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy (2022)
Attributed to:
Hydrogen sulfide as a novel guardian of the retinal vascular endothelial glycocalyx; new therapeutic opportunities.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1152/ajpheart.00001.2022
PubMed Identifier: 35302878
Publication URI: http://europepmc.org/abstract/MED/35302878
Type: Journal Article/Review
Parent Publication: American Journal of Physiology-Heart and Circulatory Physiology
Issue: 6
ISSN: 0363-6135